Dual-Purpose drug: could roxadustat fight both anemia and muscle wasting in dialysis?
NCT ID NCT07162090
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 25 times
Summary
This study looks at whether roxadustat, a drug used to treat anemia in kidney disease, can also help reduce muscle loss (sarcopenia) in people on hemodialysis. About 60 adults with end-stage kidney disease and anemia will receive either roxadustat or standard treatment. Researchers will measure muscle strength, size, and walking speed to see if roxadustat offers extra benefits beyond treating anemia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.